Search

everythinglearnresearchcommunity

for

Search:↓

New effective scar treatments are urgently needed due to the current options' limited success.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Isotretinoin's effects and side effects, like birth defects and depression, might be due to it causing cell death in various cells.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Active transdermal technologies in cosmetics help deliver skin treatments effectively, but their safety and effectiveness depend on skin type and treatment choice.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

The document suggests a need for collaboration, better evidence, and a responsible framework to safely and effectively advance regenerative therapies to clinical use.

Effective symptom management in IBD improves quality of life and prevents complications.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.

Melanoma thickness at diagnosis is linked to access to dermatologists and preventive services, not to socioeconomic status.

European dermatologic treatments focus on lifestyle and psychosocial factors, use diverse methods like baths and climate therapy, and emphasize the importance of diet and supplements for skin health.

Deep learning effectively diagnoses scalp disorders, but improvements are needed.

New evaluation tools are needed for better surgical training in dermatology residency programs.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

Ongoing research and innovation are crucial for improving skin care and treatment.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.

People with alopecia areata have similar retinal structures but thicker choroidal regions compared to those without the condition.